Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Autriche176
W. Birkmayer15
Autriche Sauf W. Birkmayer" 164
W. Birkmayer Sauf Autriche" 3
Autriche Et W. Birkmayer 12
Autriche Ou W. Birkmayer 179
Corpus4598
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 12.
Ident.Authors (with country if any)Title
002821 W. Birkmayer [Autriche] ; G. J. D. Birkmayer [Autriche]Strategy and tactic of modern Parkinson therapy
002822 G. J. D. Birkmayer [Autriche] ; W. Birkmayer [Autriche]Stimulation of endogenous L‐dopa biosynthesis — a new principle for the therapy of Parkinson's disease. The clinical effect of nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotidephosphate (NADPH)
002967 W. Birkmayer [Autriche] ; D. Birkmayer [Autriche]Iron, a new aid in the treatment of Parkinson patients
002A13 W. Birkmayer [Autriche] ; J. Knoll [Hongrie] ; P. Riederer [Autriche] ; H. Youdim [Israël] ; Vera Hars [Hongrie] ; J. Marton [Hongrie]Increased life expectancy resulting from addition of l-deprenyl to Madopar® treatment in Parkinson's disease: A longterm study
002B81 W. Birkmayer [Autriche] ; P. Riederer [Autriche] ; M. B. H. Youdim [Israël]Distinction between benign and malignant type of parkinson's disease
002C33 P. Riederer [Autriche] ; W. Birkmayer [Autriche] ; D. Seemann [Autriche] ; St. Wuketich [Autriche]Brain-noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's syndrome
002C56 W. Birkmayer [Autriche] ; P. Riederer [Autriche] ; H. Youdim [Autriche] ; W. Linauer [Autriche]The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenil
002C69 W. Birkmayer [Autriche] ; W. Danielczyk [Autriche] ; E. Neumayer [Autriche] ; P. Riederer [Autriche]Nucleus ruber and L-Dopa psychosis: Biochemical post-mortem findings
002C83 W. Birkmayer [Autriche] ; W. Danielcyk [Autriche] ; E. Neumayer [Autriche] ; P. Riederer [Autriche]L-dopa level in plasma, primary condition for the kinetic effect
002C95 W. Birkmayer [Autriche] ; W. Danielczyk [Autriche] ; E. Neumayer [Autriche] ; P. Riederer [Autriche]The balance of biogenic amines as condition for normal behaviour
002D01 W. Birkmayer [Autriche] ; E. Neumayer [Autriche]Die moderne medikamentöse Behandlung des Parkinsonismus
002D39 W. Birkmayer [Autriche] ; M. Mentasti [Autriche]Weitere experimentelle Untersuchungen über den Catecholaminstoffwechsel bei extrapyramidalen Erkrankungen (Parkinson- und Chorea-Syndrom)

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024